Accel Wealth Management - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 186 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Accel Wealth Management ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$11,453
+153.7%
1,0450.0%0.01%
+150.0%
Q4 2022$4,514
-92.3%
1,045
-86.7%
0.00%
-93.8%
Q3 2022$59,000
+1080.0%
7,855
+1519.6%
0.03%
+966.7%
Q2 2022$5,000
-16.7%
4850.0%0.00%0.0%
Q1 2022$6,000
-45.5%
4850.0%0.00%
-40.0%
Q4 2021$11,000
+37.5%
485
+38.6%
0.01%0.0%
Q3 2021$8,000
-69.2%
350
-82.4%
0.01%
-70.6%
Q2 2021$26,000
+333.3%
1,985
+309.3%
0.02%
+240.0%
Q1 2021$6,000
-14.3%
4850.0%0.01%
-28.6%
Q4 2020$7,0004850.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders